Authors


Brad Evans

Latest:

Removing Subjectivity from the Assessment of Critical Process Parameters and Their Impact

A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster, more consistent, and less subjective critical process parameter quantification, visualization, and documentation.


Jingnan Zhang

Latest:

Removing Subjectivity from the Assessment of Critical Process Parameters and Their Impact

A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster, more consistent, and less subjective critical process parameter quantification, visualization, and documentation.






SCHOTT AG, Germany

Latest:

SCHOTT on the way to ‘zero defect’ glass tubing

SCHOTT is integrating a specially developed big data solution into its pharmaceutical tubing production, replacing statistical sample-based quality assurance with 100 percent on-line measurement.


Chemspec Europe

Latest:

Chemspec Europe 2019

Chemspec Europe will take place from 26 – 27 June 2019 at Messe Basel in Switzerland.



Roquette

Latest:

New Research Reveals a Promising Functional Alternative to Surfactants within Biologic Formulations

-Research suggests cyclodextrins could replace surfactants for biologics. -Studies on HPßCD indicate it to be a potential alternative to polysorbates.



Umicore

Latest:

Umicore Precious Metals Chemistry

Umicore Precious Metals Chemistry offers a collaborative approach to research, development and commercial manufacturing of your complex organometallic chemistry and catalysis needs.


Grifols

Latest:

Grifols International, S.A.

Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide.


Anurag S. Rathore

Latest:

Near Infrared Spectroscopy as a Versatile PAT Tool for Continuous Downstream Bioprocessing

The need for real-time monitoring and control has spurred the development of new analytical tools.


Matthew Billups

Latest:

Material Traceability in Continuous Pharmaceutical Tablet Manufacturing

A systematic framework and software are needed to implement material traceability in continuous pharmaceutical tablet manufacturing.




James Drinkwater

Latest:

The Decontamination Challenge

The increase in aseptic processing driven by the growing number of biologically-derived products has led to an increase in freeze-drying applications in this area at both research and production scales.


F. Andreas Toba

Latest:

Establishing Correlation Between Aerosol and Surface Microbial Populations

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.


David A. Miller

Latest:

Establishing Correlation Between Aerosol and Surface Microbial Populations

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.


Bryan R. Campbell

Latest:

Establishing Correlation Between Aerosol and Surface Microbial Populations

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.


Debashis Sahoo

Latest:

Establishing Correlation Between Aerosol and Surface Microbial Populations

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.


Daniel Py

Latest:

Establishing Correlation Between Aerosol and Surface Microbial Populations

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.


Sade Mokuolu

Latest:

New Standards Define Single-Use Materials Qualification

Proposed guidance documents assist drug manufacturers in qualifying single-use systems for commercial drug production.


Fabia Gozzo

Latest:

The Power of Synchrotron X-Ray Powder Diffraction for the Characterization of Pharmaceuticals

X-ray powder diffraction exploits the interaction between x-rays and matter to study the structural and microstructural properties of materials.


UBM bioLIVE

Latest:

Viewpoint: 2018 a Critical Year for Maturation of European Bio Supply Chain

As Europe's growing biomanufacturing and bioprocessing industries develop, now a crucial time for the small-molecule and biopharma industries to integrate in order to facilitate growth.



K.R. Wadekar

Latest:

Determination of Related Substances in Pemetrexed Disodium (Form-IV) in Bulk Drug Samples by HPLC

The authors describe the development of a stability-indicating reverse-phase high-performance liquid chromatographic (RP?HPLC) method for the quantitative determination of potential genotoxic impurities present in pemetrexed disodium (form-IV). The chromatographic separation was achieved on a RP?HPLC column (Zorbax SB-Phenyl, Agilent) at ambient temperature with gradient elution using mobile phase A (trifluoroacetic acid [TFA] in water) and mobile phase B (TFA in acetonitrile).


Jan Vertommen

Latest:

Case Study: Fast-Track Technology Transfer of a Soft-Gelatin Capsule

Industry lessons from a fast-track technology transfer of a soft-gelatin capsule (softgel) are multifold. This case study reviews the success factors for effective execution of the technology transfer, which include: strong relationship between the customer, the contract development and manufacturing organization, and other partners based on deep knowledge in the technology; established and proven quality-by-design processes; risk mitigation management; project leadership; flawless execution; and mutual trust.


Anurag S. Rathore

Latest:

Challenges with Successful Commercialization of Biosimilars

This article presents some key differences between the US and European regulation of biosimilars, including naming conventions and pharmacovigilance of biosimilars, and the impact of biosimilars on commercialization and affordability of biotherapeutics.

© 2025 MJH Life Sciences

All rights reserved.